Loading blog posts...
October 21, 2026 • 4 min read
Industrial powerhouse 3M Company (NYSE: MMM) has released its financial results for the third quarter ended September 30, 2026. The goal today is to dig into the income statement from the company's latest 10-Q filing to see how things are going and what we can learn from the numbers. Between ongoing business transformations, the planned exit from PFAS ("forever chemicals") manufacturing, and a nearly $2 billion acquisition in the fire safety space, 3M's latest quarterly numbers reveal a business actively reshaping its core operations while expanding its profit margins.
For the third quarter of 2026, 3M reported total net sales of $6.58 billion, a modest 1.0% increase compared to $6.52 billion in the same period last year. However, that headline figure masks stronger underlying momentum. Because 3M is winding down its manufactured PFAS products, stripping out that exit impact reveals an adjusted total sales growth of 4.2% (and 3.3% organic sales growth, which excludes currency fluctuations, acquisitions, and divestitures).
Cost of sales remained steady at $3.80 billion, allowing gross profit to edge up to $2.78 billion, representing a healthy 42.3% gross margin. Operating income rose 7.7% year-over-year to $1.56 billion, pushing the GAAP operating margin up 1.5 percentage points to 23.7% (or 26.2% on an adjusted basis).
Below the operating line, GAAP net income attributable to 3M common shareholders surged 64.6% to $1.37 billion, translating to diluted earnings per share (EPS) of $2.63 (up 70% from $1.55 in Q3 2025). A major driver of this bottom-line jump was a $281 million pre-tax gain included in "Other expense (income), net" from the positive change in market value of 3M's retained ownership stake in Solventum, the healthcare business it spun off in April 2024. On an adjusted basis—which removes special items like litigation costs, restructuring, and the Solventum mark-to-market swing—diluted EPS rose a solid 12% to $2.50.
In the third-quarter income statement flow above, alongside 3M's three core business segments, there is $96 million in corporate net sales and $284 million in unallocated corporate cost of sales. These unallocated items primarily reflect commercial activity and transition arrangement agreements with Solventum following its spin-off, certain retained healthcare operations, and corporate-level costs—such as transformation restructuring, acquired intangible asset amortization, and litigation expenses—that management does not allocate directly to the operating divisions.
Looking at 3M’s three primary operating divisions highlights where growth is concentrated:
Geographically, growth was heavily skewed toward the Americas ($3.79 billion, up 5.7%), which compensated for pullbacks in Asia Pacific ($1.72 billion, down 6.5%) and EMEA ($1.08 billion, down 1.7%).
3M continues to navigate substantial legal and environmental commitments—most notably multi-district litigation and remediation efforts tied to PFAS and Combat Arms Earplugs—while executing a multi-year corporate transformation. Yet, the Q3 2026 income statement demonstrates that by leaning into high-margin industrial niches, deploying capital into targeted acquisitions like Madison Fire & Rescue, and aggressively repurchasing shares ($3.23 billion bought back in the first nine months of 2026), 3M is generating strong cash flow and steady operational improvements despite a mixed global macroeconomic environment.
Last updated: October 21, 2026
Explore prior quarterly filings, historical revenue breakdowns, and earnings trends.
3M Q2 2026: Why Net Income Jumped 29% While Operating Income Fell
Jul 22, 2026
Read
3M Q1 2026 Earnings: Operating Strength Beyond Spin-Off Noise
Apr 22, 2026
Read
3M 2025 10-K Analysis: Stability Amidst Transformation
Feb 4, 2026
Read
Inside 3M's Q3 2025 Earnings: Sales Grow, but Profits Fall on Special Charges
Oct 23, 2025
Read